Back
Danaher 10K Form
Buy
60
DHR
Danaher
Last Price:
265.64
Seasonality Move:
1.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-10-22 | 10Q | DHR/Danaher Quarterly |
| 2020-07-23 | 10Q | DHR/Danaher Quarterly |
| 2020-05-06 | 10Q | DHR/Danaher Quarterly |
| 2020-02-21 | 10K | DHR/Danaher Annual |
| 2019-10-24 | 10Q | DHR/Danaher Quarterly |
| 2019-07-18 | 10Q | DHR/Danaher Quarterly |
Receive DHR News And Ratings
See the #1 stock for the next 7 days that we like better than DHR
DHR Financial Statistics
Sales & Book Value
| Annual Sales: | $31.47B |
|---|---|
| Cash Flow: | $1.59B |
| Price / Cash Flow: | 27.26 |
| Annual Sales: | $70.06 |
| Price / Book: | 3.79 |
Profitability
| EPS (TTM): | 8.52000 |
|---|---|
| Net Income (TTM): | $6.36B |
| Gross Margin: | $18.95B |
| Return on Equity: | 13.24% |
| Return on Assets: | 7.62% |
Danaher Earnings Forecast
Key Danaher Financial Ratios
- The Gross Profit Margin over the past 39 years for DHR is 60.21%.
- The Selling, General & Administrative Expenses for DHR have been equal to 27.06% of Gross Profit Margin.
- The Research & Development expenses have been 5.54% of Revenue.
- The Interest Expense is 2.93% of Operating Income.
- The Net Earning history of DHR is 22.91% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 27 years.
Danaher Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Diagnostics & Research |
| Sector: | Healthcare |
| Current Symbol: | DHR |
| CUSIP: | 235851 |
| Website: | danaher.com |
Debt
| Debt-to-Equity Ratio: | 0.38 |
|---|---|
| Current Ratio: | 2.08 |
| Quick Ratio: | 1.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 27.49 |
|---|---|
| Forward P/E Ratio: | 27.29 |